Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.66
+0.20 (3.10%)
Aug 18, 2026, 12:21 PM EDT - Market open
Journey Medical Revenue
Journey Medical had revenue of $18.51M in the quarter ending June 30, 2026, with 23.33% growth. This brings the company's revenue in the last twelve months to $68.18M, up 20.89% year-over-year. In the year 2025, Journey Medical had annual revenue of $61.86M with 10.20% growth.
Revenue (ttm)
$68.18M
Revenue Growth
+20.89%
P/S Ratio
2.72
Revenue / Employee
$1,175,534
Employees
58
Market Cap
187.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 61.86M | 5.72M | 10.20% |
| Dec 31, 2024 | 56.13M | -23.05M | -29.11% |
| Dec 31, 2023 | 79.18M | 5.51M | 7.48% |
| Dec 31, 2022 | 73.67M | 10.54M | 16.69% |
| Dec 31, 2021 | 63.13M | 18.60M | 41.78% |
| Dec 31, 2020 | 44.53M | 9.61M | 27.52% |
| Dec 31, 2019 | 34.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 770.20M |
| Organogenesis Holdings | 457.45M |
| Aurora Cannabis | 221.16M |
| Akebia Therapeutics | 219.06M |
| Organigram Global | 217.71M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 120.65M |
| ADC Therapeutics | 79.58M |
DERM News
- 1 day ago - Journey Medical reports Q2 EPS (1c) vs. (16c) last year - TheFly
- 1 day ago - Journey Medical price target raised to $15 from $12 at B. Riley - TheFly
- 5 days ago - Journey Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Journey Medical Earnings release: Q2 2026 - Filings
- 5 days ago - Journey Medical Quarterly report: Q2 2026 - Filings
- 5 days ago - Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 13 days ago - Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 - GlobeNewsWire
- 6 weeks ago - Journey Medical Slides: Investor presentation - Filings